首页> 美国卫生研究院文献>EJIFCC >Integration of multigene panels for the diagnosis of hereditary retinal disorders using Next Generation Sequencing and bioinformatics approaches
【2h】

Integration of multigene panels for the diagnosis of hereditary retinal disorders using Next Generation Sequencing and bioinformatics approaches

机译:使用下一代测序和生物信息学方法整合多基因面板以诊断遗传性视网膜疾病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In recent years, Next-Generation Sequencing (NGS) opened a new way for the study of pathogenic mechanisms and for molecular diagnosis of inherited disorders. In the present work, we focused our attention on the inherited retinal dystrophies (IRDs), a group of specific disorders of the retina, displaying a very high clinical and genetic heterogeneity, whose genetic diagnosis is not easily feasible. It represents a paradigmatic example for the integration of clinical and molecular examination toward precision medicine.In this paper, we discuss the use of targeted NGS resequencing of selected gene panels in a cohort of patients affected by IRDs. We tested the hypothesis to apply a selective approach based on a careful clinical examination. By this approach we reached a 66% overall detection rate for pathogenic variants, with a 52% diagnostic yield. Reduction of the efforts for validation and classification of variants is a clear advantage for the management of genetic testing in a clinical setting.
机译:近年来,下一代测序(NGS)为研究致病机制和遗传性疾病的分子诊断开辟了一条新途径。在当前的工作中,我们将注意力集中在遗传性视网膜营养不良(IRD)上,这是一组视网膜的特定疾病,显示出很高的临床和遗传异质性,其遗传诊断不容易。它代表了将临床和分子检查整合为精密医学的范例。在本文中,我们讨论了针对选定的基因组的靶向NGS重测序在一组受IRD影响的患者中的应用。我们通过仔细的临床检查检验了该假设以应用选择性方法。通过这种方法,我们达到了66%的病原体变异总检出率,诊断率为52%。减少验证和分类变体的工作量是临床环境中基因检测管理的明显优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号